Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point

BACKGROUND: The availability of large epidemiological or clinical data storing biological samples allow to study the prognostic value of novel biomarkers, but efficient designs are needed to select a subsample on which to measure them, for parsimony and economical reasons. Two-phase stratified sampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Graziano, Francesca, Valsecchi, Maria Grazia, Rebora, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091513/
https://www.ncbi.nlm.nih.gov/pubmed/33941092
http://dx.doi.org/10.1186/s12874-021-01283-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091513/
https://www.ncbi.nlm.nih.gov/pubmed/33941092
http://dx.doi.org/10.1186/s12874-021-01283-0

Ejemplares similares